Delhi High Court orders takedown of fake Kotak accounts on Meta, Telegram, LinkedIn

New Delhi, Oct. 28 -- The Delhi High Court has directed major social media platforms including Meta, Google, Telegram, X, and LinkedIn to remove hundreds of fraudulent accounts impersonating Kotak Mah... और पढ़ें

Paras Healthcare gains on debut

Mumbai, Oct. 28 -- The scrip was listed at 720, at a premium of 3.9% compared with the initial public offer (IPO) price. The counter hit a high of Rs 747.45 and a low of Rs 705.75. About 3.97 lakh sh... और पढ़ें

One killed in petrol pump explosion in Odisha's Nilagiri

Bhubaneswar, Oct. 28 -- One person was reportedly killed in an explosion at a petrol pump near Nilagiri bus stand in Odisha's Balasore on Wednesday. According to reports, the blast occurred while a ta... और पढ़ें

Saudi-Led Coalition Intercepts Houthi Ballistic Missile Over Taif

Afghanistan, Oct. 28 -- Saudi-led coalition said it intercepted and destroyed a ballistic missile launched by Yemen's Houthis towards the western Saudi city of Taif early Wednesday, October 28, as cro... और पढ़ें

Scotland's First Minister John Swinney meets Karan Johar and Apoorva Mehta at Dharma Productions

Mumbai, Oct. 28 -- Scotland's First Minister John Swinney visited Dharma Productions, where he met filmmaker Karan Johar and CEO Apoorva Mehta to explore opportunities for closer collaboration between... और पढ़ें

NZ Dollar Falls As RBNZ Holds Key Rate Defying Market Expectation

India, Oct. 28 -- The New Zealand dollar weakened against other major currencies in the Asian session on Wednesday, as the Reserve Bank of New Zealand or the RBNZ unexpected interest rate weighed on t... और पढ़ें

Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo... और पढ़ें

Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabili... और पढ़ें

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ... और पढ़ें

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4174794 in Participants with Obesity or Overweight who are Otherwise Healthy

Singapore, Oct. 28 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to ... और पढ़ें

• ««
• «
• 2566
• 2567
• 2568
• 2569
• 2570
• 2571
• 2572
• 2573
• 2574
• 2575
• »
• »»